Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04551144 · ClinicalTrials.gov registry record
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
A clinical trial, sponsored by St. Louis University.
- Terminated
- Registry status
- 4
- Enrollment target
NCT04551144: Clinical Trial study, sponsored by St. Louis University.
NCT04551144 is a clinical trial that was terminated before completion, run by St. Louis University. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04551144 was terminated before completion, sponsored by St. Louis University.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.
Primary Outcome
change in Androgen receptor expression in subcutaneous adipose tissue in transmen
Interventions
- DRUG testosterone cypionate
- DRUG Estradiol Valerate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2020-10-06 |
| Est. Completion | 2023-01-18 |
Why NCT04551144 stopped before completion
NCT04551144 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which testosterone cypionate is the first listed.
NCT04551144 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04551144 about?
NCT04551144 is a clinical study titled "Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors". The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.
What is the current status of trial NCT04551144?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2020-10-06. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT04551144?
The interventions under investigation include: testosterone cypionate (DRUG), Estradiol Valerate (DRUG).
Who is sponsoring clinical trial NCT04551144?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI